Post kidney transplant histoplasmosis: An under-recognized diagnosis in India.


Journal

Transplant infectious disease : an official journal of the Transplantation Society
ISSN: 1399-3062
Titre abrégé: Transpl Infect Dis
Pays: Denmark
ID NLM: 100883688

Informations de publication

Date de publication:
Jun 2021
Historique:
revised: 04 10 2020
received: 01 06 2020
accepted: 01 11 2020
pubmed: 23 11 2020
medline: 4 8 2021
entrez: 22 11 2020
Statut: ppublish

Résumé

Histoplasmosis is an invasive mycosis caused by fungus Histoplasma capsulatum. Clinical features of histoplasmosis are often nonspecific, but patients with disseminated infection may present with severe manifestations posing an increasing threat to patients with various immunocompromised conditions. It is often misdiagnosed as tuberculosis in endemic regions leading to high mortality. There is under-reporting of histoplasmosis in solid organ transplant from India undermining its actual incidence and impact. As a result of the potentially fatal nature of the disease, careful evaluation with tissue diagnosis is recommended. We present a series of five cases of disseminated histoplasmosis in renal transplant recipients from our centre, highlighting its significance as differential diagnosis in this population. To our knowledge, this is the largest case series reported from India in renal transplant patients.

Identifiants

pubmed: 33222373
doi: 10.1111/tid.13523
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13523

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Wang JH, Skeans MA, Israni AK. Current status of kidney transplant outcomes: dying to survive. Adv Chronic Kidney Dis. 2016;23(5):281-286.
Bige N, Zafrani L, Lambert J, et al. Severe infections requiring intensive care unit admission in kidney transplant recipients: impact on graft outcome. Transpl Infect Dis. 2014;16(4):588-596.
Randhawa HS, Gugnani HC. Occurrence of histoplasmosis in the Indian Sub-Continent: an overview and update. J Med Res Pract. 2018;7:71-83.
Newman SL, ed. Cell-mediated immunity to Histoplasma capsulatum. Semin Respir Infect. 2001;16(2):102-108.
Assi M, Martin S, Wheat LJ, et al. Histoplasmosis after solid organ transplant. Clin Infect Dis. 2013;57(11):1542-1549.
Ostrosky-Zeichner L, Sobel JD. Fungal Infections, An Issue of Infectious Disease Clinics of North America, 1st edn. Elsevier Health Sciences; 2016:xiii-xiv. https://doi.org/10.1016/j.idc.2015.12.001
Cuellar-Rodriguez J, Avery R, Lard M, et al. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis. 2009;49(5):710-716.
Einollahi B, Lessan-Pezeshki M, Pourfarziani V, et al. Invasive fungal infections following renal transplantation: a review of 2410 recipients. Ann Transplant. 2008;13(4):55-58.
Kauffman CA, Freifeld AG, Andes DR, et al. Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET). Transpl Infect Dis. 2014;16(2):213-224.
Miller R, Assi M, Practice AIDCo. Endemic fungal infections in solid organ transplant recipients-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13553.
Wheat LJ, Slama TG, Norton JA, et al. Risk factors for disseminated or fatal histoplasmosis: analysis of a large urban outbreak. Ann Intern Med. 1982;96(2):159-163.
Fuller DD, Davis TE, Denys GA, York MK. Evaluation of BACTEC MYCO/F Lytic medium for recovery of mycobacteria, fungi, and bacteria from blood. J Clin Microbiol. 2001;39(8):2933-2936.
Hage CA, Ribes JA, Wengenack NL, et al. A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis. 2011;53(5):448-454.
Richer SM, Smedema ML, Durkin MM, et al. Improved diagnosis of acute pulmonary histoplasmosis by combining antigen and antibody detection. Clin Infect Dis. 2016;62(7):896-902.
Wheat LJ, Hackett E, Durkin M, et al. Histoplasmosis-associated cross-reactivity in the BioRad Platelia Aspergillus enzyme immunoassay. Clin Vaccine Immunol. 2007;14(5):638-640.
Freifeld AG, Wheat LJ, Kaul DR. Histoplasmosis in solid organ transplant recipients: early diagnosis and treatment. Curr Opin Organ Transplant. 2009;14(6):601-605.
Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45(7):807-825.
Lobo V, Joshi A, Khatavkar P, Kale M. Pulmonary histoplasmosis in a renal allograft recipient. Indian J Nephrol. 2014;24(2):120.
Jha V, Sree VK, Varma N, et al. Disseminated histoplasmosis 19 years after renal transplantation. Clin Nephrol. 1999;51(6):373-378.
Chawla A, Chawla K, Thomas J. Genitourinary histoplasmosis in post-renal transplant patient: diagnostic dilemma. Indian J Urol. 2012;28(3):359.
Evans R, Bhagani S, Haque T, Harber M. Infectious complications of transplantation. Practical Nephrol. 2014;829-856.

Auteurs

Abhyudaysingh Rana (A)

Department of Nephrology and Renal Transplant Medicine, Medanta - The Medicity, Gurguram, Haryana, India.

Camille N Kotton (CN)

Transplant and Immunocompromised Host Infectious Diseases, Infectious Diseases Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Amit Mahapatra (A)

Department of Nephrology and Renal Transplant Medicine, Medanta - The Medicity, Gurguram, Haryana, India.

Ashish Nandwani (A)

Department of Nephrology and Renal Transplant Medicine, Medanta - The Medicity, Gurguram, Haryana, India.

Sidharth Sethi (S)

Department of Nephrology and Renal Transplant Medicine, Medanta - The Medicity, Gurguram, Haryana, India.

Shyam B Bansal (SB)

Department of Nephrology and Renal Transplant Medicine, Medanta - The Medicity, Gurguram, Haryana, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH